Abstract

Adipose triglyceride lipase (ATGL) catalyzes the first step in triglyceride (TAG) hydrolysis. Because most studies have focused on ATGL in adipose tissue, its role and function in other tissues is relatively unknown. To elucidate the metabolic functions of hepatic ATGL, we employed gain and loss‐of‐function studies in primary hepatocyte cultures and adenovirus‐mediated knockdown in vivo. ATGL overexpression in primary hepatocyte cultures exhibited resistance to fatty acid‐induced steatosis, increased catabolism of hydrolyzed fatty acids and increased PPAR‐α activity. Treament of hepatocytes with siRNA against ATGL resulted in decreased rates of TAG hydrolysis and increased TAG accumulation along with suppressed fatty acid oxidation and PPAR‐α activity. However, the large changes in TAG turnover and fatty acid oxidation did not affect media TAG suggesting that rates of VLDL synthesis were unaltered. Interestingly, ATGL shRNA‐treated mice exhibited 150% more hepatic TAG and increased liver weight. Serum TAG levels of the mice did not change in response to ATGL knockdown while the expression of PPAR‐α and its target genes decreased, thus supporting the previous data from in vitro studies. Taken together, these data show that ATGL is a major TAG lipase in the liver that acts, perhaps in part through PPAR‐α, to channel hydrolyzed fatty acids towards oxidative pathways as opposed to VLDL secretory pathways.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.